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The use of gold nanoparticles (AuNPs) as labeling carriers in combination with the 
enzymatic activity of the Horseradish Peroxidase (HRP) in order to achieve an 
improved optical lateral flow immunoassay (LFIA) performance is here presented. 
Briefly in a LFIA with an immune-sandwich format AuNPs are functionalized with a 
detection antibody already modified with HRP, obtaining an “enhanced” label. Two 
different detection strategies have been tested: the first one following just the red color 
of the AuNPs and the second one using a substrate for the HRP (3 different substrates 
are evaluated), which produces a darker color that enhances the intensity of the previous 
red color of the unmodified AuNPs. In such very simple way it is gained sensitivity (up 
to 1 order of magnitude) without losing the simplicity of the LFIA format, opening the 
way to other LFIA applications including their on-demand performance tuning 
according to the analytical scenario.  
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1. INTRODUCTION  
The detection of protein is of tremendous interest in diagnostics, since many biomarkers 
for many diseases are actually proteins and their early detection could save many lives, 
especially in the third world countries (Mabey et al., 2004). In fact, whereas in the 
industrialized world many complex and expensive techniques are available, in third 
world countries these techniques cannot be used because of their high cost and the lack 
of trained personnel (Yager et al., 2006; Ellerbee et al., 2009). The same situation can 
be found in small ambulatory, remote regions and battlefields. In this context the 
development of easy to use, point of care (PoC) and cheap biosensors is essential. A 
possible answer to this demand is the Lateral Flow Immunoassay (LFIA), which is a 
platform that can be defined as ASSURED: affordable, sensitive, specific, user-friendly, 
rapid and robust, equipment free and deliverable to end-users (Peeling et al., 2006; 
“http://www.who.int/std_diagnostics/about_SDI/priorities.htm,” n.d.). LFIA is based on 
the recognition of one or more analytes of interest, mainly proteins, by using antibodies. 
The antibodies are fixed onto a nitrocellulose membrane and they interact with the 
analyte either in sandwich or competitive formats using a proper label. The main 
advantage compared with other immunosensors is that the entire assay can be done in 
one step and in few minutes (Posthuma-Trumpie et al., 2009). On the other hand the 
limit of detection (LoD) is generally not as good as other assays like ELISA; this 
limitation is the main reason to the lack of extensive use in clinical laboratories, even 
being one of the most used PoC biosensors, since the first pregnancy test sold in 1970s.  
On the other hand, nanomaterials (NMs) and especially nanoparticles have been widely 
used in many biosensors ranging from protein (de la Escosura-Muñiz et al., 2010) to 
nucleic acid (Alegret et al., 2005) detection and with different techniques (both optical 
and electrochemical) due to their unique properties which make them excellent labels 
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and carriers. Gold nanoparticles (AuNPs) are the most used NM in LFIA (Lou et al., 
2011; Yang et al., 2011) but not the only one; actually also magnetic nanoparticles, 
quantum dots (QDs) (Zou et al., 2010; Zhu et al., 2011), liposomes (Edwards and 
Baeumner, 2006; Shukla et al., 2011), carbon nanotubes (Wang et al., 2009, 2012; 
Abera and Choi, 2010), carbon  nanoparticles (Ornatska et al., 2011) have also been 
used for such purposes. Although the peculiar properties of materials help to increase 
the sensitivity of the LFIA, this must be further increased to expand the application 
range in diagnostics. One of these advantageous properties consists in their ability to act 
as carriers of a high number of enzymes so as to increase their availability to catalyze 
the detection reaction. This approach was already performed in different biosensors like 
ELISA (Ambrosi et al., 2010) and lateral flow for nucleic acid (He et al., 2011)(Mao et 
al., 2009). 
 In this article we discuss the development of a LFIAs based on the use of AuNPs not 
only as labels but also as carriers of enzymatic labels. AuNPs produce red bands at the 
detection and control lines of the LFIA when acting as direct labels; but if they are 
coupled with an antibody modified with HRP they can also act as carriers. 3,3′,5,5′-
Tetramethylbenzidine (TMB); 3-Amino-9-ethylcarbazole (AEC); 3,3′-
Diaminobenzidine tetrahydrochloride (DAB)  with Metal Enhancer as substrates of the 
HRP are evaluated since they produce insoluble chromogens which cannot be moved by 
the flow, concentrating the color at the lines. The developed LFIAs offer two different 
detection alternatives: one produced just by the red color of the AuNPs and one more 
sensitive produced by the substrate of the HRP achieving an ‘on-demand’ tuning of the 
biosensing performance. Its application for protein detection, after related optimizations, 
could open the way to several uses with interest in diagnostics, safety and security 
between other fields. 
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2. EXPERIMENTAL SECTION 
2.1. Materials 
All the materials used for the production of the LFIA strips were purchased from 
Millipore (Billerica MA 08128; USA):  sample and absorbent pads (CFSP001700), 
conjugation pad (GFCP00080000), detection pad (SHF2400425) and the backing card 
(HF000MC100). A guillotine Dahle 533 (Germany) was used to cut the strips. The 
sample pad buffer consisted in 10mM PBS pH 7.4 with 5% BSA and 0.05% Tween20; 
the conjugation pad buffer was 2mM borate buffer pH 7.4 with 10% of sucrose; the 
antibody buffer was 10 mM phosphate pH 7.4. An IsoFlow reagent dispensing system 
(Imagene Technology, USA) was used to dispense the detection and control lines. A 
strip reader (COZART – SpinReact, U.K.) was used for quantitative measurements. 
Hydrogen tetrachloroaurate (III) trihydrate (HAuCl4.3H2O, 99.9%) and trisodium citrate 
(Na3C6H5O7.2H2O) were purchased from Sigma-Aldrich (Spain) to synthesize AuNPs. 
A Transmission Electron Microscope (TEM) Jeol JEM-2011 (Jeol Ltd, Japan) and a 
scanning electron microscope Merlin®FE-SEM (Carl Zeiss, Germany) were 
used to characterize the AuNPs.  
For the AuNP conjugation: the borate buffer solution (BB) was prepared with 0.1M 
boric acid and adjusted to pH 9.2 with 5M NaOH. Blocking buffer solution consisted in 
mQ water with 1 mg/mL bovine serum albumin (BSA). The stirrer used was a TS-100 
Thermo shaker (Spain). A thermostatic centrifuge Sigma 2-16 PK (Fisher Bioblock 
Scientific, France) was used to purify the conjugates of AuNPs/antibodies. 
Human IgG whole molecule (I2511), anti-human IgG whole molecule (produced in 
goat; I1886), anti-human IgG γ chain specific HRP modified (produced in goat; A6029) 
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and all the chemical reagents (analytical grade) used for the preparation of buffer 
solutions were purchased from Sigma-Aldrich (Spain). Anti-goat IgG (produced in 
chicken; ab86245) was purchased from Abcam (U.K.). 
The HRP substrates: TMB (T0565); AEC (AEC101); DAB with Metal Enhancer 
(D0426) were purchased from Sigma-Aldrich (Spain). 
mQ water, produced using Milli-Q system (>18.2MΩcm-1) purchased from Millipore 
(Sweden), was used for the preparation of all the solutions.   
2.2. Methods 
Preparation and modification of gold nanoparticles 
AuNPs of 20 nm of diameter were prepared according with the citrate reduction of 
HAuCl4, method pioneered by Turkevich (Turkevich, 1951), as stated in the 
supplementary material.  
The prepared AuNPs were further modified with the antibody anti-human IgG γ chain 
specific HRP modified. The functionalization process is described in the supplementary 
material. The AuNPs/antibody conjugates were further centrifuged at 14000 rpm for 20 
min at 4º C in order to concentrate them 5 times in 2 mM borate buffer pH 7.4 with 10% 
of sucrose. 
Preparation of the LFIA strips 
First the sample pad was prepared dipping it into a sample pad buffer solution and then 
drying it at 60º C for 2 hour. The conjugation pad was prepared soaking it with the 
AuNPs/antibody conjugate, prepared as described above, and then drying it at room 
temperature under vacuum for 2 hours. Finally the antibodies anti-human IgG whole 
molecule and anti-goat IgG, diluted in the antibody buffer at a concentration of 1 
mg/mL, were spotted onto the detection pad to form the detection and control lines 
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respectively, using the IsoFlow reagent dispensing system. The detection pad was dried 
at 37º C for 1 hour. 
The different pads were subsequently laminated onto the baking card with an overlap 
between them of around 2 mm, in order to allow the sample to flow (see figure 1). 
Finally they were cut 8 mm wide and stored in dry conditions at 4º C up to a week 
(longer storage times were not assayed, although it is known that these kind of strips, 
like i.e. those used for pregnancy tests can be stored for many weeks)  
(Preferred position for Figure 1) 
 
LFIA procedure 
Sample solutions were prepared diluting different amounts of Human IgG (HIgG) in 
PBS, obtaining different analyte concentration: 0.5 ng/mL, 5 ng/mL, 50 ng/mL, 500 
ng/mL. PBS without analyte was considered as blank. The assay procedure consisted in 
first dispensing of 200 l of sample solution onto the sample pad and waiting during 15 
minutes untill the flow is stopped. Then 200 l PBS were dispensed in order to wash 
away the excess of AuNPs/antibody. The strips were read with the strip reader to obtain 
the calibration curve corresponding to the AuNPs used as ‘direct’ labels. After the first 
reading step, the LFIA strips were dipped for 5 min into the different HRP substrates 
and washed with mQ water to stop the reaction and prevent a saturation of the signals. 
The strips were finally read again with the reader. 
 
3. RESULTS AND DISCUSSION 
3.1. AuNP/antibody conjugates characterization 
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The AuNPs were characterized first by UV-Vis analysis to calculate their concentration 
(it resulted 2.1x10
-4
 M) and to have an estimation of their size, which resulted to be 
around 20 nm in diameter since the wavelength of the peak was 520 nm (de la Escosura-
Muñiz et al., 2011) (figure 1S-A). Then they were also visualized by transmission 
electron microscopy (TEM) to have a more accurate size distribution, giving as result  a 
diameter of 21 ± 3 nm (figure 1S-B).  
The detection lines obtained for different concentrations of HIgG were visualized also 
by scanning electron microscopy (SEM). In the figure 1S-C it is possible to see the 
AuNPs (the white spots) in the test line of a LFIA after detecting 500 ng/mL of HIgG, 
whereas figure 1S-D shows another zone of the detection pad without AuNPs. 
 
3.2. Evaluation of the LFIA performance using AuNPs as both direct labels and 
carriers of enzymatic labels  
The prepared LFIA strips gave rise to two different signals. The first one consists in the 
red color of the AuNPs, whereas the second one corresponds to the color of the 
chromogen produced by the enzymatic activity of the HRP. The red color of the AuNPs 
enables to detect up to around 50 ng/mL of HIgG for naked eyes. The strip reader gives 
as output a % value corresponding to the intensity of the lines: stronger the color lower 
is the % value (figure 2). A linear relationship between this value and the logarithm of 
the HIgG concentration was found (see Supplementary Material). The limit of detection 
using the reader was calculated as the concentration of HIgG corresponding to three 
times the standard deviation of the isof 2 ng/mL Although the obtained sensitivity can 
be considered adequate for some applications it is not enough for others, whose required 
detection limits are lower. For this reason the TMB, AEC and DAB with metal enhancer 
were tested as HRP substrates in the developed LFIA. 
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The first HRP substrate tested was the TMB. As stated in the experimental section the 
TMB used in these experiments produced an insoluble blue-violet chromogen, which is 
deposited at the level of the control and test lines (as shown in figure 2); in this way the 
color is not dispersed along the strip. After stopping the HRP activity the strips were 
read with the strip reader. The results obtained are shown in the graph of figure 2, where 
the improvement in the sensitivity seems to be clear. By using non-modified AuNPs as 
labels it was difficult to distinguish between a blank and 5 ng/mL of HIgG with the 
naked eye; on the other hand using the TMB the difference between the blank and the 
samples is evident, even at 5 ng/mL. The limit of detection obtained using the reader 
(calculated as explained before; see the quantification equation at the Supplementary 
Material) was of 200 pg/mL.. 
(Preferred position for Figure 2) 
The second substrate used was the AEC, which produces an insoluble red chromogen. 
This substrate was already used by Liu’s group in a LF for the detection of nucleic acids 
(He et al., 2011)(Mao et al., 2009). As in the case of TMB substrate also the AEC 
enables increasing the sensitivity of the assay, allowing to detect up to  5 ng/mL with 
the naked eye as shown in figure 2. The limit of detection using the strip reader was in 
this case 0.31 ng/mL (see equation at the Supplementary Material)..  
Finally the DAB with metal enhancer was tested. This HRP-substrate developed a 
grey/black insoluble compound. Surprisingly, it did not produce any appreciable 
increment in the sensitivity of the LFIA, being the minimum concentration detected 
with the naked eye of around 50 ng/mL, as also shown in figure 2. The limit of 
detection using the reader (see equation at the Supplementary Material) was only a little 
bit lower (1.6 ng/mL) than the obtained for the unmodified AuNPs (2ng/mL, as 
explained before). 
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It is also noticed a higher colored background in the case of the enzymatic reactions, 
probably due to a not completely washing of the strips. 
The reproducibility responses of 50 ng/mL HIgG, n = 3, give a relative standard 
deviation (RSD) of 1.3% for AuNPs, 5.6% for TMB, 1.5% for AEC and 16% for DAB.. 
It seems to be clear that the use of the enzymatic reactions catalyzed by the HRP loaded 
on AuNPs using TMB and AEC as substrates of the enzyme allows an enhancing of the 
sensitivity of the LFIA of around one order of magnitude compared to the results 
obtained just from the direct measurement of the AuNPs as non modified optical labels. 
In particular the TMB was the substrate which gave the best limit of quantification 
compared with the others (figure 2). TMB is also cheaper compared with DAB 
Furthermore it has an important advantage compared to the other substrates studied in 
this work: it is ready to use. In fact both AEC and DAB need to be prepared freshly, 
using deionized water and mixing of at least two reagents. These characteristics make 
these two substrates not so suitable for LFIA applications, since they are more time 
consuming and could increase the possibility of human errors leading to an increase of 
the irreproducibility of the results. It has also to be noted that the AEC produces a red 
chromogen which color can be added to the red color of the AuNPs and the background 
resulted less intense than the one of the TMB. 
 
4. CONCLUSIONS 
A LFIA strip, with AuNPs loaded with HRP enzymatic labels was obtained. The use of 
such a label allows increasing an order of magnitude the limit of quantification in a 
LFIA for the detection of Human IgG used as model protein. The strips prepared gave 
two different detection ranges: one less sensitive considering just the red color of the 
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AuNPs and one more sensitive considering the color produced by the HRP substrates. 
Three different HRP substrates were tested and the TMB was resulted the most suitable 
for LFIA applications compared with AEC and DAB with metal enhancer. This result 
could open the way to the use of LFIA in more diagnostics applications, especially in an 
ambulatory/laboratory context, due to the lower limit of quantification obtained. 
Furthermore, the use of various substrates offers the possibility to the ‘on-demand’ 
tuning of the sensitivity of the device adapting it to the analytical scenario.  
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Figure 1. (A) Scheme of the LFIA for the detection of HIgG. (B) Detail of  the different 
parts of a LFIA strip and cartoons representing the AuNP modified with the antibody 
anti-human IgG γ chain specific HRP modified, and the different colors expected for the 
different substrates (TMB, AEC and DAB) used. 
Figure 2. (Left) Photos of the LFIA strips for different concentrations of HIgG and the 
different substrates. (Right) Graph of the results obtained with the strip reader. 
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Preparation of gold nanoparticles 
Gold nanoparticles of 20 nm of diameter were prepared according with the citrate 
reduction of HAuCl4, method pioneered by Turkevich.(Turkevich, 1951) Briefly: 50 mL 
aqueous solution of 0.01% HAuCl4 was heated to boiling and vigorously stirred in a 250 
mL round-bottom flask; 5 mL of 40 mM sodium citrate were added quickly to this 
solution. Boiling was continued for additional 10 min. The solution was cooled to room 
temperature with a continuous stirring for another 15 min. The colloids were stored in 
dark bottles at 4° C. All glassware used in this preparation was thoroughly cleaned in 
aqua regia overnight and rinsed with double distilled H2O and reflux was used for all 
the procedure.  
 
AuNPs modification with antibodies 
The antibody anti-human IgG γ chain specific HRP modified was conjugated to the 
AuNPs: the pH of 1.5 mL of AuNPs was corrected to 7.4 with borate buffer. Then 100 
μL of the antibody solution (100 μg/mL) were added drop by drop and the resulting 
solution was incubated for 20 min at 650 rpm. Then 100 μL of 1 mg/mL BSA in H2O 
mQ were added drop by drop and the stirring was continued for other 20 min at 650 
rpm. Finally the solution was centrifuged at 14000 rpm for 20 min. The supernatant was 
removed and the pellet of AuNPs was re-suspended in 300 μL of 2 mM borate buffer 




 Figure S1. (A) UV-Vis spectra of AuNPs. (B) TEM image of AuNPs. (C) SEM image 
of the test line of the LFIA detecting 500 ng/mL HIgG; the white spots represent the 








Figure S2. Scheme of the strip sizes. 
 
 
 
